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Downstream of costimulatory pathways, complexes of transcription factors NFAT and AP-1 promote effector
T cell differentiation. In this issue of Immunity, Martinez et al. report that monomeric NFAT binding in the
absence of a transcriptional partner induces a gene expression program involved in T cell exhaustion.T cell exhaustion is a type of T cell
dysfunction that occurs in many chronic
infections and cancer. Hallmarks of T cell
exhaustion include reduced effector func-
tion, expression of inhibitory receptors
(e.g., programmed cell death-1 [PD-1]),
and distinct transcriptional and metabolic
states. Recently, checkpoint blockade
targeting inhibitory receptors expressed
by exhausted T (Tex) cells such as PD-1
has shown great promise in patients with
advanced cancer. In contrast to effector
T (Tef) cells generated in the presence of
adequate T cell receptor (TCR) stimulation
and costimulation, Tex cells arise in the
context of high and prolonged antigen
stimulation and excess of coinhibitory
over costimulatory signals. However, our
understanding of how T cells integrate
this information into the transcription of
‘‘exhaustion’’ versus ‘‘effector’’ gene pro-
grams remains limited.
Several transcriptional circuits have
been implicated in Tex cells including tran-
scription factors T-bet and Eomes, Blimp-
1, hypoxia-inducible factors, Foxo1, the
AP-1 family member BATF, and NFAT
(Kahan et al., 2015). Some transcriptionfactors like BATF might regulate early
TCR-dependent expression of other tran-
scription factors shared between Tex
and Tef cells. Other transcriptional circuits
have been described in Tex versus func-
tional T cells. Transcriptional network
analysis highlighted the context-depen-
dent nature of key transcription factors ex-
pressed by Tex cells, indicating that these
transcription factors can be linked to dif-
ferential gene expression in Tex compared
to functional T cells (Doering et al.,
2012). For example, quantitative changes
in T-box transcription factors (e.g., T-bet,
Eomes) are associated with exhaustion
compared to memory development.
Despite this work it remains unclear what
the earliest transcriptional control points
are that govern the development of func-
tional versus dysfunctional T cells.
In this issue of Immunity, Martinez et al.
(2015) show that different modes of tran-
scription factor NFAT binding underlie the
expression of exhausted versus effector
transcriptional programs (Figure 1). Lym-
phocytes express NFAT family members
1, 2, and 4 that get activated by TCR-
induced, calcium-dependent, calcineurin-mediated dephosphorylation of cytosolic
NFAT and subsequent nuclear transloca-
tion. In addition to a DNA binding domain,
NFATs contain domains that allow pro-
tein-protein interactions with other tran-
scriptional cofactors. Such a system al-
lows integration of transcriptional inputs
downstream of costimulatory and other
regulatory signals. For example, in Tef
cells, binding of AP-1 complexes formed
downstream of costimulatory signaling
pathways is critical for transcription of
T cell effector proteins, such as inter-
leukin-2 (IL-2) and interferon-g (IFN-g).
Importantly, lack of transcriptional coop-
eration between NFAT and other tran-
scription factors is involved in T cell
anergy, a distinct type of dysfunctional
T cells that contributes to peripheral toler-
ance (Mu¨ller and Rao, 2010). Anergic
CD4+ T cells are induced by TCR engage-
ment without costimulation, a scenario
that activates NFAT in the absence of
AP-1 and initiates transcription of anergy-
related genes. A different regulatory
mechanism involving NFAT occurs in
regulatory T cells, where NFAT co-binding
with FOXP3 results in transcriptionalFebruary 17, 2015 ª2015 Elsevier Inc. 203
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Figure 1. Cooperative NFAT:AP-1 Transcription Factor Binding Sites Are Preferentially
Found at Effector Gene Transcriptional Start Sites
In the context of TCR signaling and appropriate costimulation (e.g., via CD28), NFAT and AP-1 will coop-
erate to induce an effector gene program. However, in T cell exhaustion, lack of functional AP-1 availability
will result in NFAT binding to monomeric binding sites located at TSSs of exhaustion-related genes, such
as multiple inhibitory receptors and immunoregulatory genes.
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(Mu¨ller and Rao, 2010).
But do exhausted cells actually require
NFAT? Some previous evidence sug-
gested a role for NFAT in Tex cells (Kahan
et al., 2015), yet exactly how this tran-
scription factor functioned in this context
was unclear. In this issue of Immunity,
Martinez et al. (2015) demonstrate mark-
edly diminished expression of inhibitory
receptors and effector cytokines in acti-
vated T cells genetically deficient in
NFAT1 and 2. The residual expression of
these proteins was further reduced by
NFAT4 knockdown, suggesting that all
calcium-regulated lymphocytic NFAT
family members contribute to both the
effector and exhaustion program. Even
during LCMV clone 13 infection, a widely
used mouse model of chronic infection204 Immunity 42, February 17, 2015 ª2015 Eand T cell exhaustion, exhaustion did not
develop without functional NFAT1 and 2,
though whether NFAT-deficient T cells
undergo normal initial activation and
expansion during infection is not clear.
Nevertheless, these findings demonstrate
anNFAT requirement for the development
of T cell exhaustion.
The authors employed an elegant
approach to study the properties of
NFAT binding to promoter regions in the
absence of AP-1 by using a constitutively
active variant of NFAT1 mutated to
abolish AP-1 binding (CA-RIT-NFAT1).
This construct is expected to bind in a
monomeric fashion (i.e., without AP-1) to
DNA. In-vitro-activated T cells expressing
this construct displayed reduced IL-2 pro-
duction and attenuated T cell signaling.
Further, expression of CA-RIT-NFAT1lsevier Inc.interfered with T cell effector function in
two in vivo models. First, CA-RIT-NFAT1-
expressing CD8+ T cells were impaired in
their ability to protect during Listeria
monocytogenes infection. Similarly to
Tex cells described in chronic viral infec-
tions, CA-RIT-NFAT1-transduced cells
had higher expression of inhibitory
receptors including PD-1, Tim-3, and
LAG-3. Second, CA-RIT-NFAT-1-trans-
duced T cells were unable to reject CT26
tumor cells and again displayed high
inhibitory receptor coexpression. These
findings indicate that NFAT1 binding in
the absence of AP-1 fosters a program of
T cell dysfunction resembling exhaustion.
To define the molecular and tran-
scriptional mechanisms by which NFAT
binding in the absence of AP-1
regulated exhaustion, the authors per-
formed genome-wide RNA-seq of
CA-RIT-NFAT1-transduced cells. Large
alterations of the transcriptome were
identified compared to control trans-
duced cells, affecting 2,000 genes that
overlapped significantly with exhausted
and anergic gene sets. Importantly,
several key molecules involved in T cell
exhaustion were directly upregulated by
CA-RIT-NFAT1, including inhibitory re-
ceptors (e.g., LAG-3, Tim-3, PD-1), tran-
scription factors (e.g., Blimp-1), and other
immunoregulatory proteins (e.g., diacyl-
glycerol kinase). These data suggest that
NFAT binding in the absence of AP-1
drives expression of a key set of exhaus-
tion-related genes.
Additional ChIP-seq studies demon-
strated that CA-RIT-NFAT1 bound to tran-
scriptional start sites (TSSs) of genes
identified as upregulated by RNA-seq,
such as Lag3. No such association was
found with downregulated genes, sug-
gesting that monomeric NFAT1 functions
as a positive regulator of gene expression.
In addition, WT NFAT1 bound to approxi-
mately twice as many genomic sites as
CA-RIT-NFAT1, indicating that at least
half the genes regulated by WT NFAT
probably require additional binding of
transcriptional cofactors, such as AP-1.
Finally, a composite NFAT1:AP-1 binding
element was enriched in regions bound
by WT NFAT1 but not CA-RIT-NFAT1. In
contrast, monomeric NFAT1 binding ele-
ments were dominant in the setting of
CA-RIT-NFAT1 binding, including binding
to TSSs of inhibitory receptor genes (e.g.,
PD-1, CTLA-4, Tim-3, LAG-3). Thus,
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effector function are typically character-
ized by promoters and/or enhancers
harboring a composite NFAT1:AP-1 bind-
ing element, whereas NFAT-regulated
genes involved in T cell dysfunction
displaymonomeric NFAT1 bindingmotifs.
These findings imply that monomeric
NFAT binding motifs constitute a genetic
coding for genes involved in T cell
dysfunction such as exhaustion.
These data suggest that T cell receptor
stimulation in the presence of insufficient
positive costimulation (i.e., a major source
for AP-1 signals) could be important for
T cell exhaustion. This notion is supported
by results from the LCMV model showing
that high amounts of antigen stimulation,
including that presented by non-profes-
sional antigen-presenting cells, are linked
to T cell exhaustion (Mueller and Ahmed,
2009). Indeed, a major role for inhibitory
receptors such as PD-1 might be
to disrupt the AP-1 signals generated
through positive signaling cascades
(Quigley et al., 2010) and to shift the rela-
tive ratio of nuclear NFAT:canonical AP-1
complexes to an excess of ‘‘partnerless’’
NFAT favoring exhaustion (Figure 1).
It should be noted, however, that NFAT-
dependent gene expression is not suffi-
cient for the development of all aspects
of T cell exhaustion, but rather seems
to contribute to an early transcriptional
check point. Exhaustion is a progressive
process. For example, T cells primed
during chronic LCMV infection maintain
fate flexibility during the effector phase
and can develop into functional memory
T cells if removed from infection within
1 week. This plasticity wanes over
time, however, suggesting that an irre-versible program of exhaustion becomes
further established during extended
chronic stimulation. These observations
are consistent with the role for Eomes
found in exhaustion (Paley et al., 2012)
that appears to be independent of the
monomeric NFAT pathway described
in the current work. Nevertheless, the
early NFAT-driven expression of inhibitory
receptors (such as PD-1) and other regu-
latory proteins illustrated in this new
work could allow for the integration of
additional feed-forward signals that rein-
force development of exhaustion (e.g.,
after PDL1:PD-1 ligation). These signals
might then add additional layers to
the transcriptional program of T cell
exhaustion. One example might be the
control of cell fate and metabolism ex-
erted through signals mediated by the
PD-1 pathway. Indeed, a recent study
described a feedback loop for PD-1
signaling that activates the transcription
factor FoxO1, which in turn sustains
PD-1 expression and homeostasis of ex-
hausted T cell populations (Staron et al.,
2014).
A better understanding of the role
of NFAT:AP-1 transcriptional interactions
might have therapeutic implications. For
example, this new work suggests that re-
establishment of cooperative NFAT1:AP-
1 binding might be an effective strategy
to reverse T cell exhaustion. Induction of
AP-1 family members has been reported
downstream of several costimulatory
pathways, such as CD28 or TNF family
members OX40, 4-1BB, and CD27
(Chen and Flies, 2013). Indeed, significant
increases in T cell function have been re-
ported when costimulatory pathways
were activated alone or in combinationImmunity 42,with PD-1 blockade (Vezys et al., 2011).
Thus, these new findings not only shed
light on the transcriptional role for NFAT
in T cell exhaustion and provide a
genomic and mechanistic understanding
for this process, but could also provide a
framework for rationally selecting optimal
combinations of immunotherapy in set-
tings of T cell exhaustion like cancer and
chronic infections.REFERENCES
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